SCHEMBL5238729

SCHEMBL5238729

O=C(CC1CCCCC1)NCCCc1cccc(N2CC3CN(C(=O)c4c(F)cccc4Cl)CC3C2)c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.41
RAB9A P51151 5/20 0.38
NPC1 O15118 4/20 0.38
HCRTR1 O43613 4/20 0.37
HCRTR2 O43614 4/20 0.37
CCR5 P51681 2/20 0.37
SIGMAR1 Q99720 1/20 0.37
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NAMPT P43490 1/20 0.35
DRD2 P14416 1/20 0.34
ADRA1A P35348 1/20 0.34
DRD3 P35462 1/20 0.34
CHRM4 P08173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5232680 0.99 EPHX2 (0.40) EPHX2RAB9ANPC1HCRTR1HCRTR2
SCHEMBL5236149 0.91 MAPK1 (0.40) RAB9AHCRTR1HCRTR2CCR5SIGMAR1
SCHEMBL5237863 0.88 SIGMAR1 (0.41) HCRTR1HCRTR2SIGMAR1
SCHEMBL5236854 0.87 HPGD (0.43) HCRTR1HCRTR2SIGMAR1SMN1; SMN2NAMPT
SCHEMBL5233648 0.87 HCRTR1 (0.42) RAB9ANPC1HCRTR1HCRTR2SIGMAR1
SCHEMBL5233381 0.86 HCRTR1 (0.41) HCRTR1HCRTR2SIGMAR1
SCHEMBL5233744 0.86 ALDH1A1 (0.41) HCRTR1HCRTR2SIGMAR1
SCHEMBL5237363 0.86 HCRTR1 (0.39) HCRTR1HCRTR2SIGMAR1
SCHEMBL5235733 0.86 SIGMAR1 (0.44) NPC1HCRTR1HCRTR2SIGMAR1SMN1; SMN2
SCHEMBL5234808 0.85 HCRTR1 (0.38) RAB9AHCRTR1HCRTR2SIGMAR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-A2 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 EP claimed
WO-2005121145-A2 OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 WO claimed